Evidence map›Paper›PMID 39503526›Full record

ArticleEpilepsia2025

Imaging blood-brain barrier dysfunction in drug-resistant epilepsy: A multi-center feasibility study.

Nir Cafri, Sheida Mirloo, Daniel Zarhin, Lyna Kamintsky, Yonatan Serlin, Laith Alhadeed, Ilan Goldberg, Mark A Maclean, Ben Whatley, Ilia Urman and 12 more

Abstract readMulticenter Study
In one paragraph

Article in Epilepsia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Nir CafriDepartment of Physiology, Professor Vladimir Zelman Inter-Disciplinary Center of Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.ORCID 0009-0008-2238-9973
Sheida MirlooDepartment of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.
Daniel ZarhinDepartment of Neurology, Rabin Medical Center, Beilinson Hospital and Tel-Aviv University, Petah Tikva, Israel.
Lyna KamintskyDepartment of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.
Yonatan SerlinDepartment of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.
Laith AlhadeedDepartment of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.
Ilan GoldbergDepartment of Neurology, Rabin Medical Center, Beilinson Hospital and Tel-Aviv University, Petah Tikva, Israel.
Mark A MacleanDivision of Neurosurgery, Dalhousie University, Halifax, Nova Scotia, Canada.
Ben WhatleyDivision of Neurology, Dalhousie University, Halifax, Nova Scotia, Canada.
Ilia UrmanDepartment of Neurology, Rabin Medical Center, Beilinson Hospital and Tel-Aviv University, Petah Tikva, Israel.
Colin P DohertyAcademic Unit of Neurology, School of Medicine, Trinity College, Dublin, Ireland.
Chris GreeneFutureNeuro, Science Foundation Ireland Research Centre for Chronic and Rare Neurological Diseases, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland.
Claire BehanAcademic Unit of Neurology, School of Medicine, Trinity College, Dublin, Ireland.ORCID 0000-0001-6528-513X
Declan BrennanAcademic Unit of Neurology, School of Medicine, Trinity College, Dublin, Ireland.
Matthew CampbellFutureNeuro, Science Foundation Ireland Research Centre for Chronic and Rare Neurological Diseases, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland.
Chris BowenDepartment of Diagnostic Radiology, Dalhousie University, Halifax, Nova Scotia, Canada.
Gal Ben-ArieDepartment of Medical Imaging, Soroka Medical Center, Beer Sheva, Israel.
Ilan ShelefDepartment of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
Britta WandschneiderDepartment of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
Matthias KoeppDepartment of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0002-4277-8000
Alon FriedmanDepartment of Physiology, Professor Vladimir Zelman Inter-Disciplinary Center of Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.ORCID 0000-0003-4780-8456
Felix BenningerDepartment of Neurology, Rabin Medical Center, Beilinson Hospital and Tel-Aviv University, Petah Tikva, Israel.ORCID 0000-0003-3097-4693

Funding

Canadian Institute of Health Research 488048,PJT-180636European Research Council 864522Irish Research Council 3948Israel Science Foundation 2254/20Medical Research Council T005335/1Network of European Funding for Neuroscience Research (NEURON ERA-NET) 168164Neurosurgery Research and Education FoundationScience Foundation Ireland 3732United States - Israel Binational Science Foundation
6 · The paper itself

Abstract

objectiveBlood-brain barrier dysfunction (BBBD) has been linked to various neurological disorders, including epilepsy. This study aims to utilize dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to identify and compare brain regions with BBBD in patients with epilepsy (PWE) and healthy individuals.

methodsWe scanned 50 drug-resistant epilepsy (DRE) patients and 58 control participants from four global specialized epilepsy centers using DCE-MRI. The presence and extent of BBBD were analyzed and compared between PWE and healthy controls.

resultsBoth greater brain volume and higher number of brain regions with BBBD were significantly present in PWE compared to healthy controls (p < 10 SIGNIFICANCE: These findings are consistent with pre-clinical studies that highlight the role of BBBD in the development of DRE and identify microvascular stabilization as a potential therapeutic strategy.

Indexed as

Blood-Brain BarrierBrainDrug Resistant EpilepsyAdolescentAdultFeasibility StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedYoung Adultbiomarkersblood–brain barrierdrug resistanceepilepsymagnetic resonance imaging

Identifiers

PMID39503526
PMCPMC11742632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.